These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease. Mendler MH; Kanel G; Govindarajan S Liver Int; 2005 Apr; 25(2):294-304. PubMed ID: 15780053 [TBL] [Abstract][Full Text] [Related]
5. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Mofrad P; Contos MJ; Haque M; Sargeant C; Fisher RA; Luketic VA; Sterling RK; Shiffman ML; Stravitz RT; Sanyal AJ Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006 [TBL] [Abstract][Full Text] [Related]
6. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661 [TBL] [Abstract][Full Text] [Related]
7. The histologic spectrum of nonalcoholic fatty liver disease. Contos MJ; Choudhury J; Mills AS; Sanyal AJ Clin Liver Dis; 2004 Aug; 8(3):481-500, vii. PubMed ID: 15331059 [TBL] [Abstract][Full Text] [Related]
8. Spectrum of histological features in non-alcoholic fatty liver disease. Vasdev N; Kakati AG; Saigal S; Nayak NC Natl Med J India; 2007; 20(6):282-7. PubMed ID: 18335793 [TBL] [Abstract][Full Text] [Related]
9. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462 [TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789 [TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis. Akyol G; Erdem O; Yilmaz G Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770 [TBL] [Abstract][Full Text] [Related]
13. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease]. Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885 [TBL] [Abstract][Full Text] [Related]
14. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473 [TBL] [Abstract][Full Text] [Related]
15. The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery. Ziolkowski A; Wylezol M; Kukla M; Zwirska-Korczala K; Berdowska A; Pardela M; Gabriel A Obes Surg; 2005 Oct; 15(9):1309-14. PubMed ID: 16259893 [TBL] [Abstract][Full Text] [Related]
16. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [TBL] [Abstract][Full Text] [Related]
17. High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease. Forlano R; Mullish BH; Giannakeas N; Maurice JB; Angkathunyakul N; Lloyd J; Tzallas AT; Tsipouras M; Yee M; Thursz MR; Goldin RD; Manousou P Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2081-2090.e9. PubMed ID: 31887451 [TBL] [Abstract][Full Text] [Related]
18. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042 [TBL] [Abstract][Full Text] [Related]
19. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Bedossa P; Hepatology; 2014 Aug; 60(2):565-75. PubMed ID: 24753132 [TBL] [Abstract][Full Text] [Related]
20. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. Adams LA; Sanderson S; Lindor KD; Angulo P J Hepatol; 2005 Jan; 42(1):132-8. PubMed ID: 15629518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]